Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide for neuroprotection after cardiac arrest
NCT06572085Phase 4Recruiting
- Start
- Jan 2022
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of butylphthalide in cardiac arrest (SCA). Started Jan 2022; status: recruiting.
02
Drugs
butylphthalide
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT06572085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06572085.